Showing results (121-130 of 243) with videos related to
Sort By:
Pageof 25
Plos One|April 1, 2017
Plasma complement and vascular complement deposition in patients with coronary artery disease with and without inflammatory rheumatic diseasesKelly J Shields, Tom Eirik Mollnes, Jon Roger Eidet, et al.BMC Medical Genetics|January 13, 2011
Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosusSudeshna Dasgupta, F Yesim Demirci, Amy S Dressen, et al.American Journal of Respiratory and Critical Care Medicine|March 2, 2021
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled TrialRoham T Zamanian, David Badesch, Lorinda Chung, et al.Annals of the Rheumatic Diseases|February 13, 2025
LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trialsEric F Morand, Ronald van Vollenhoven, Richard A Furie, et al.Rheumatology (Oxford, England)|March 17, 2009
Association between depression and coronary artery calcification in women with systemic lupus erythematosusCarol M Greco, Amy H Kao, Abdus Sattar, et al.Translational Stroke Research|December 11, 2013
Relation of platelet C4d with all-cause mortality and ischemic stroke in patients with systemic lupus erythematosusAmy H Kao, Christine A McBurney, Abdus Sattar, et al.Journal of Medical Genetics|March 15, 2017
Multiple signals at the extended 8p23 locus are associated with susceptibility to systemic lupus erythematosusF Yesim Demirci, Xingbin Wang, David L Morris, et al.The American Journal of Cardiology|July 6, 2013
Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosusAmy H Kao, Apinya Lertratanakul, Jennifer R Elliott, et al.Journal of Scleroderma and Related Disorders|February 2, 2019
Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group ReportJohn D Pauling, Tracy M Frech, Michael Hughes, et al.Arthritis and Rheumatism|November 6, 2004
Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosusSusan Manzi, Jeannine S Navratil, Margie J Ruffing, et al.Pageof 25